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Effectiveness of a lifestyle intervention led by female 
community health volunteers versus usual care in blood 
pressure reduction (COBIN): an open-label, 
cluster-randomised trial
Dinesh Neupane, Craig S McLachlan, Shiva Raj Mishra, Michael Hecht Olsen, Henry B Perry, Arjun Karki, Per Kallestrup
Summary
Introduction Elevated blood pressure greatly contributes to cardiovascular deaths in low-income and middle-income 
countries. We aimed to investigate the effectiveness of a population-level intervention led by existing community 
health workers in reducing the burden of hypertension in a low-income population.
Methods We did a community-based, open-label, two-group, cluster-randomised controlled trial in Nepal. Using 
computer-generated codes, we randomly assigned (1:1) 14 clusters to a lifestyle intervention led by female community 
health volunteers (FCHVs) or usual care (control group). In the intervention group, 43 FCHVs provided home visits 
every 4 months for lifestyle counselling and blood pressure monitoring. Eligible participants had been involved in a 
previous population-based survey, were aged 25–65 years, did not have plans to migrate outside the study area, and 
were not severely ill or pregnant. The primary outcome was mean systolic blood pressure at 1 year. We included all 
participants who remained in the trial at 1 year in the primary analysis. This trial is registered with ClinicalTrials.gov, 
number NCT02428075.
Findings Between April 1, 2015, and Dec 31, 2015, we recruited 1638 participants (939 assigned to intervention; 
699 assigned to control). At 1 year, 855 participants remained in the intervention group (425 were normotensive, 
175 were prehypertensive, and 255 had hypertension) and 613 remained in the control group (305 were normotensive, 
128 were prehypertensive, and 180 had hypertension). The mean systolic blood pressure at 1 year was significantly lower 
in the intervention group than in the control group for all cohorts: the difference was –2·28 mm Hg (95% CI –3·77 to 
–0·79, p=0·003) for participants who were normotensive, –3·08 mm Hg (–5·58 to –0·59, p=0·015) for participants who 
were prehypertensive, and –4·90 mm Hg (–7·78 to –2·00, p=0·001) for participants who were hypertensive.
Interpretation A simple, FCHV-led lifestyle intervention coupled with monitoring of blood pressure is effective for 
reduction of blood pressure in individuals with hypertension and ameliorates age-related increases in blood pressure 
in adults without hypertension in the general population of Nepal.
Funding Aarhus University, Jayanti Memorial Trust.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
Introduction
Elevated blood pressure is the biggest risk factor 
contributing to the global incidence of cardiovascular 
death.1 In the past four decades, blood pressure has 
decreased in high-income countries (HICs), whereas 
it has increased in low-income countries (LICs) in 
southern Asia and sub-Saharan Africa.2 Without 
interventions for elevated blood pressure, we are unlikely 
to meet the target of reducing by a third premature 
mortality from non-communicable diseases, as set in the 
2015 UN Sustainable Development Goals.3 A 5 mm Hg 
reduction in systolic blood pressure in the population 
has been estimated to result in a 14% overall reduction 
in mortality due to stroke, a 9% reduction in mortality 
due to coronary heart disease, and a 7% reduction in all-
cause mortality.4 Even modest population-wide 
reductions in systolic blood pressure (eg, 1 mm Hg) are 
predicted to have substantial effects on cardiovascular 
death prevention.5 Hence, this strategy for reducing 
premature cardio vascular mor bidity, mortality, and 
burden is cost-effective, with use of few health resources.6
WHO aims to achieve a 25% relative reduction in the 
prevalence of hypertension by 2025.7 To achieve this 
objective, population-level interventions focusing on low-
income and middle-income countries (LMICs) are needed. 
One way to address the emerging hypertension burden in 
LMICs could be to involve community health workers, 
such as those in the Female Community Health Volunteer 
(FCHV) programme in Nepal.8 FCHVs are trained 
community health workers who provide basic health 
services in Nepal. They are selected by members of 
Mothers’ Group for Health with the help of staff at local 
health facilities. FCHVs receive 18 days of basic training, in 
two phases, on selected primary health-care components. 
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The main role of an FCHV is to promote health and 
healthy behaviours in the community to improve safety of 
motherhood, child health, and family planning.9 Generally, 
health-seeking practice for non-communicable diseases is 
low in Nepal. Hypertension remains undiagnosed because 
it is often asymptomatic and most of the population are 
never screened for elevated blood pressure. People only 
visit the doctor when they are feeling seriously ill.
Although many studies10 have investi gated the role of 
community health workers in improving maternal and 
child health, reports of lifestyle inter ventions led by 
community health workers for blood pressure control 
are scarce. Previous randomised trials investigating 
mobilisation of community health workers for reduction 
of blood pressure have mostly been confined to HICs and 
focused on patients diagnosed with hypertension.11 A 
study12 in children and young adults in Pakistan showed a 
small but significant difference in blood pressure between 
children and young adults in the intervention group and 
those in the control group. Another study13 in Pakistan by 
the same group did not yield conclusive results for an 
effect of mobilisation of community health workers on 
blood pressure reduction in patients with hypertension.
We aimed to assess the effectiveness of an FCHV-led 
lifestyle intervention and screening of blood pressure in 
reducing blood pressure in individuals who are normo-
tensive, prehypertensive, or hypertensive in Nepal.
Methods
Study design and participants
The community-based management of hypertension in 
Nepal (COBIN) trial was an open-label, two-group, 
cluster-randomised controlled trial designed to establish 
the effectiveness of FCHV-led home-based health 
education and screening of blood pressure in adults in 
Nepal.14 The trial was approved by the ethics review 
committee of Nepal Health Research Council (reference 
number 1065). Participants gave writ ten informed consent.
The sampling frame and study design has been 
described previously.14 Feasibility studies15,16 before 
implementation of the trial have been published. Briefly, 
we did a community-based survey to estimate the 
prevalence of hypertension in Lekhnath municipality, 
Nepal.17 The total population of the municipality in a 
2011 census18 was 58 816. The municipality is divided 
into 15 smaller units called wards. Each ward—with the 
exception of one ward that was excluded because it was 
different from the other wards in terms of geographical 
accessibility and service availability—was considered 
one cluster in the study. The municipality health services 
comprised one primary health-care centre, three sub-
health posts, and two urban health-care centres. During 
the survey, individuals were asked whether they would 
like to participate in this study. Eligible participants were 
aged 25–65 years, consented to participate in the study, 
did not have plans to migrate outside the study area, 
and had participated in the prevalence study. People 
were excluded if they declined consent or were severely 
ill, unlikely to be in the community throughout the 
intervention, or pregnant.
Randomisation and masking
A biostatistician, who had no previous knowledge of the 
clusters, used computer-generated codes to randomly 
Research in context
Evidence before this study
We did a systematic review of randomised controlled trials 
assessing community health worker-led interventions for blood 
pressure reduction. To identify trials, we searched PubMed and 
the Cochrane Central Register of Controlled trials up to 
Dec 31, 2016, using the search terms “blood-pressure” 
OR “hypertension” OR “raised-blood-pressure” 
OR “high-blood-pressure” AND “community-health-worker”. 
We found 30 completed and 21 ongoing trials investigating 
involvement of community health workers in blood pressure 
management. Most of these studies were from Europe, 
North America, and Australia; only three studies were from 
low-income countries (LICs; two from Pakistan and one from 
Ghana). Of the completed trials, nine involved patients with 
diabetes, ten involved patients with hypertension, and 
four involved patients with coronary heart disease. None of the 
studies from LICs used community health workers to 
implement lifestyle interventions and to monitor blood 
pressure. The interventions used in these studies involved 
one or a combination of individualised or personalised health 
education delivered by community health workers (lifestyle 
modification, drug reconciliations), clinic-based follow-up, 
home-based blood pressure monitoring, and pharmacological 
treatment. Evidence is conflicting on the effects of these 
interventions on blood pressure.
Added value of the study
This study is the first to assess the effectiveness of a community 
health worker-led lifestyle intervention and blood pressure 
monitoring in reduction of blood pressure in normotensive, 
prehypertensive, and hypertensive populations in an LIC. 
We showed that female community health volunteer (FCHV)-led 
health education (lifestyle intervention) and blood pressure 
screening over a 1 year period in Nepal led to a significantly lower 
mean systolic blood pressure in the intervention group than in 
the control group.
Implications of all the available evidence
The potential for FCHVs to control blood pressure in this 
population might lead to scaling up of the intervention to the 
national level. The strategy might also be replicated in other 
low-income and middle-income countries that have a strong 
network of community health workers.
Articles
www.thelancet.com/lancetgh   Vol 6  January 2018 e68
assign (1:1) 14 clusters to the intervention group or 
control group. Participants and investigators were not 
masked to group assignment for practical reasons.
Procedures
After randomisation, 46 FCHVs were invited to a 5 day 
intensive training course on blood pressure (FCHVs did 
not receive any training in blood pressure monitoring 
before this study). They were trained in burden of non-
communicable diseases or hypertension; identification 
of blood pressure risk factors with a checklist comprising 
salt intake, physical inactivity, smoking, and alcohol 
consumption; blood pressure screening with digital 
sphygmomanometers; height and weight measurements; 
referral procedures for partici pants with blood pressures 
of higher than 140/90 mm Hg; personalised health 
promotion counselling on major risk factors; and 
recording, reporting, and follow-up procedures. The 
training materials were developed after consultation 
with experts and stakeholders and with guidance from 
the Health Belief Model.19 The materials were pretested 
in FCHVs in another municipality. At the end of training, 
three FCHVs withdrew from the study because they 
could not properly read blood pressure measurements.
FCHVs visited selected households three times a year 
(every 4 months) to provide health promotion counselling 
and to measure blood pressure. On average, one FCHV 
visited 20 households three times a year. When visiting a 
household, an FCHV measured the blood pressure, 
height, and weight of the participant according to standard 
procedures. During the visit, the FCHV delivered the 
lifestyle counselling intervention, focusing on increasing 
physical activity, lowering salt consumption, reducing 
alcohol consumption, avoiding smoking, and decreasing 
stress. If a participant had a high blood pressure, they 
were referred to the nearest health facility and, if on 
antihypertensive medication, were also followed up for 
adherence to their medi cation during the FCHV visit.
One field supervisor was responsible for supervising 
the 43 FCHVs. All participants in the control group 
received usual care pertaining to current practices for 
hypertension management at the community level.
To establish whether the intervention was imple-
mented as planned, a register developed for the purpose 
of this trial was used by FCHVs to record dates, times, 
and activities. The FCHV activities were cross-verified by 
the field supervisor and were confirmed during the 
follow-up survey by asking participants whether FCHVs 
had adhered to the protocol. We also used a supervision 
checklist to track and update the knowledge and skill 
levels of FCHVs.
After 1 year of intervention, a follow-up survey was done 
by trained professional health workers (eg, nurses and 
health assistants) who were not involved in the baseline 
survey. To reduce the effects of diurnal variation and 
seasonality on blood pressure measurements, all baseline 
and follow-up home visits and blood pressure measure-
ments were taken in the first half of the day at the same 
time of year. Three blood pressure measurements were 
taken with the Omron HEM-7203 blood pressure monitor 
(Omron, Kyoto, Japan) in 5 min intervals for precision, 
and the mean of the last two readings was included in 
the analyses.
Outcomes
The primary outcome was 1 year mean systolic blood 
pressure in participants who were normotensive, pre-
hypertensive, or hypertensive. Normotension was defined 
as a systolic blood pressure of less than 120 mm Hg and a 
diastolic blood pressure of less than 80 mm Hg, in the 
absence of antihypertensive treatment. Prehypertension 
was defined as a systolic blood pressure of 120–139 mm Hg 
and a diastolic blood pressure of 80–89 mm Hg, in the 
absence of antihypertensive treatment. Hypertension was 
defined as a systolic blood pressure of 140 mm Hg or 
higher, a diastolic blood pressure of 90 mm Hg or higher, 
or use of anti hyper tensive medication.20 Secondary 
outcomes were change in mean diastolic blood pressure 
and percentage change in proportion of risk factors 
(smoking, alcohol consum ption, high salt intake, and low 
physical activity). Infor mation about smoking, alcohol 
consumption, fruit and vegetable intake, and physical 
activity was self-reported, whereas salt intake was 
measured by dividing the amount of table salt used in the 
past 24 h by the number of people who consumed salt. In 
our study setting, the diet of participants was such that salt 
intake other than table salt was minimal. Low physical 
activity was defined as less than 3000 metabolic equivalent 
of tasks (METs) of vigorous or moderate activity each 
week.21,22 Daily tobacco users were respondents who 
reported smoking cigarettes, bidi, kankat, or hukka or 
using other forms of smokeless tobacco on a daily basis. 
We defined harmful alcohol use as 15 or more standard 
drinks a week for men and eight or more standard drinks a 
1638 participants enrolled and randomly assigned (1:1) 
 in 14 clusters
939 in 7 clusters allocated to intervention
 453 normotensive
 204 prehypertensive
 282 hypertensive
699 in 7 clusters allocated to usual care
 346 normotensive
 149 prehypertensive
 204 hypertensive
855 analysed
 425 normotensive
 175 prehypertensive
 255 hypertensive
613 analysed
 305 normotensive
 128 prehypertensive
 180 hypertensive
62 lost to follow-up (died, migrated, could 
  not be found during follow-up survey)
22 discontinued intervention (dropout)
86 lost to follow-up (died, migrated, or
  could not be found during follow-up 
  survey)
Figure 1: Trial profile
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week for women.23 Participants consuming fewer than five 
servings of fruit or vegetables a day were categorised as low 
fruit and vegetable consumers.24 One serving of vegetables 
was defined as one cup of raw, leafy green vegetables; half 
a cup of other cooked or raw vegetables; or half a cup of 
vegetable juice. One serving of fruit was defined as one 
medium-sized piece of fruit; half a cup of raw, cooked, or 
canned fruit; or half a cup of juice from a fruit (not 
artificially flavoured).19
Statistical analysis
We assumed a mean difference in systolic blood pressure 
of 5 mm Hg between the control group and the inter-
vention group after 1 year, with SDs of 18·8 for 
participants who were normotensive, 13·6 for partici-
pants who were prehypertensive, and 15·7 for participants 
who were hypertensive, and an intracluster correlation 
coefficient of 0·01.9,25 Thus, the sample size required for 
80% power was 1638 (812 in the normotensive cohort, 
336 in the prehypertensive cohort, and 490 in the hyper-
tensive cohort). 2815 eligible participants were available 
from the community-based prevalence survey.17 To 
establish the number of participants that should be 
recruited from each ward, for each ward we multiplied 
the required sample size (ie, 1638) by the proportion of 
eligible participants in that ward. We then selected 
participants from each ward using systematic random 
sampling. Because of different size clusters, the total 
number of participants in the intervention group and the 
control group was not matched.
All quantitative analyses were done with Stata 
version 14. We included all participants who remained in 
Normotension Prehypertension Hypertension
Intervention 
(n=425)
Control 
(n=305)
Intervention 
(n=175)
Control 
(n=128)
Intervention 
(n=255)
Control  
(n=180)
Age (years) 42·17 (9·79) 42·25 (9·52) 46·02 (9·73) 45·15 (9·92) 50·12 (8·99) 50·28 (8·14)
Sex
Female 335 (79%) 238 (78%) 122 (70%) 88 (69%) 134 (53%) 115 (64%)
Male 90 (21%) 67 (22%) 53 (30%) 40 (31%) 121 (47%) 65 (36%)
Body-mass index ( kg/m²) 24·09 (4·22) 23·70 (3·98) 25·44 (4·53) 26·22 (3·89) 25·58 (4·23) 26·23 (4·44)
Systolic blood pressure (mm Hg) 108·24 (6·93) 108·54 (6·89) 124·27 (7·07) 125·50 (7·09) 142·71 (16·96) 144·19 (19·19)
Diastolic blood pressure (mm Hg) 71·75 (5·56) 71·95 (5·19) 81·76 (4·98) 82·44 (5·13) 91·83 (9·57) 93·08 (10·83)
Current smoker 70 (16%) 46 (15%) 23 (13%) 17 (13%) 51 (20%) 27 (15%)
Harmful alcohol consumption* 19 (4%) 18 (6%) 21 (12%) 16 (13%) 55 (22%) 35 (19%)
High salt intake† 342 (80%) 267 (88%) 144 (82%) 109 (85%) 189 (74%) 144 (80%)
Low physical activity‡ 17 (4%) 10 (3%) 11 (6%) 5 (4%) 31 (12%) 6 (3%)
Low fruit and vegetable intake§ 382 (90%) 280 (92%) 156 (89%) 115 (90%) 224 (88%) 167 (93%)
Diabetes 8 (2%) 5 (2%) 2 (1%) 4 (3%) 19 (7%) 16 (9%)
Family history of hypertension 159 (37%) 110 (36%) 68 (39%) 50 (39%) 93 (36%) 81 (45%)
Receiving antihypertensive medication ·· ·· ·· ·· 88 (35%) 62 (34%)
Data are mean (SD) or n (%). *Eight standard drinks per week for women and 15 per week for men. †More than 5 mg per day. ‡Less than 3000 metabolic equivalent of tasks. 
§Fewer than five servings per day. 
Table 1: Baseline characteristics
Normotension Prehypertension Hypertension
Intervention 
(n=425)
Control 
(n=305)
Intervention 
(n=175)
Control 
(n=128)
Intervention 
(n=255)
Control 
(n=180)
Systolic blood pressure (mm Hg) 112·63 (10·87) 115·15 (12·07) 124·69 (10·31) 128·38 (13·35) 136·24 (15·46) 141·34 (20·07)
Diastolic blood pressure (mm Hg) 76·33 (7·49) 77·07 (7·72) 83·24 (7·25) 84·96 (8·01) 88·93 (10·55) 91·97 (13·01)
Current smoker 68 (16%) 48 (16%) 22 (13%) 19 (15%) 53 (21%) 31 (17%)
Harmful alcohol consumption* 38 (9%) 32 (10%) 20 (11%) 10 (8%) 58 (23%) 35 (19%)
High salt intake† 331 (78%) 261 (86%) 129 (74%) 98 (77%) 187 (73%) 135 (75%)
Low physical activity‡ 22 (5%) 28 (9%) 11 (6%) 17 (13%) 33 (13%) 26 (14%)
Low fruit and vegetable intake§ 417 (98%) 300 (98%) 169 (97%) 124 (97%) 245 (96%) 175 (97%)
Receiving antihypertensive medication 4 (1%) 5 (2%) 7 (4%) 9 (7%) 91 (36%) 70 (39%)
Data are mean (SD) or n (%). *Eight standard drinks per week for women and 15 per week for men. †More than 5 mg per day. ‡Less than 3000 metabolic equivalent of tasks. 
§Fewer than five servings per day.
Table 2: Characteristics at 1 year
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the trial at 1 year in the primary analysis. Analyses were 
adjusted for age, sex, cluster, and baseline blood pressure. 
We excluded missing data (n=170) from the analyses. We 
modelled systolic blood pressure at follow-up using 
random-effects mixed regression. The effect size of the 
primary outcome is reported as mean difference with 
95% CI. We calculated relative risk (RR) to estimate the 
incidence of hypertension after adjusting for age, sex, 
and cluster.
This trial is registered with ClinicalTrials.gov, number 
NCT02428075.
Role of the funding source
The funders had no role in study design, participant 
selection, data collection, and data analyses. The cor-
responding author had full access to the data in the study 
and final responsibility for the decision to submit for 
publication.
Results
Between April 1, 2015, and Dec 31, 2015, 1638 participants 
in 14 clusters were randomly assigned to the intervention 
group (n=939) or control group (n=699; figure 1). At 
1 year of intervention, nine people had died, 39 had 
migrated, 100 had been lost to follow-up, and 22 had 
discontinued the intervention.
Table 1 shows the baseline characteristics of the 
1468 (90%) participants who remained in the study at 
1 year. At baseline, the mean systolic blood pressure was 
122 mm Hg and the mean diastolic blood pressure was 
80 mm Hg. 234 (16%) participants were smokers, 
164 (11%) were drinking alcohol in amounts harmful to 
their health, and 80 (5%) had low physical activity.
Table 2 shows the follow-up characteristics of the 
participants who remained in the study at 1 year. 
59 (10%) of 600 participants who were normotensive or 
prehypertensive in the intervention group and 66 (15%) 
of 433 participants who were normotensive or 
prehypertensive in the control group had newly 
developed hypertension at 1 year. Four times the number 
of participants who were prehypertensive at baseline as 
those who were normotensive at baseline had progressed 
to hypertension at 1 year (22 [5%] of 425 vs 37 [21%] of 
175 in the intervention group and 25 [8%] of 305 vs 
41 [32%] of 128 in the control group). At 1 year, the risk of 
participants who were normotensive or prehypertensive 
at baseline developing hypertension (adjusted for base-
line age, sex, and cluster) was 53% higher in the control 
group than in the intervention group (RR 1·53, 95% CI 
1·05–2·23).
The mean systolic blood pressure (adjusted for age, 
sex, and baseline systolic blood pressure) increased 
between baseline and follow-up by 4·39 mm Hg in the 
intervention group and 6·61 mm Hg in the control group 
for participants who were normotensive and by 0·42 mm 
Hg in the intervention group and 2·88 mm Hg in the 
control group for participants who were prehypertensive 
(figure 2 and table 3). For participants who were 
hypertensive at baseline, the mean systolic blood 
pressure decreased by 6·47 mm Hg in the intervention 
group and 2·85 mm Hg in the control group (figure 2 
and table 3).
The mean diastolic blood pressure of participants who 
were normotensive increased between baseline and 
follow-up by 4·58 mm Hg in the intervention group and 
5·12 mm Hg in the control group. For participants who 
were prehypertensive, mean diastolic blood pressure 
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Figure 2: Change in systolic blood pressure from baseline to follow-up for 
participants who were normotensive (A), prehypertensive (B), 
or hypertensive (C)
Articles
e71 www.thelancet.com/lancetgh   Vol 6  January 2018
increased by 1·48 mm Hg in the intervention group and 
2·52 mm Hg in the control group. The mean diastolic 
blood pressure of participants who were hypertensive 
decreased by 2·90 mm Hg in the intervention group and 
1·11 mm Hg in the control group. The differences in 
change in systolic blood pressure between the intervention 
group and the control group for normotensive, prehyper-
tensive, and hypertensive cohorts were significant; 
how ever, the differences in change in diastolic blood 
pressure were only significant for participants with 
hypertension (table 4).
We did not find significant differences between the 
intervention and control groups at follow-up in terms of 
proportions of people who smoked daily (odds ratio 0·79, 
95% CI 0·46–1·37), consumed 5 g or more of salt each 
day (0·80, 0·56–1·14), ate less than five servings of fruit 
and vegetables each day (1·09, 0·38–3·13), consumed 
harmful amounts of alcohol (1·07, 0·61–1·90), had low 
physical activity (0·77, 0·24–2·45), and were not taking 
antihypertensive medication (1·44, 0·69–3·00).
Discussion
We showed that an FCHV-led lifestyle intervention 
could effectively reduce mean systolic blood pressure in 
patients with hypertension and ameliorate the usual 
age-related increase in mean systolic blood pressure in 
individuals who were normotensive or prehypertensive 
in a general population in Nepal. A study26 from the 
Framingham Heart Study showed a consistent linear 
increase in systolic blood pressure with age in normo-
tensive and prehypertensive groups. We found that the 
RR of developing hypertension was higher in the control 
group than in the intervention group. This finding 
might explain the higher use of medication in the 
control group than in the intervention group because 
successful lifestyle interventions in individuals who 
were prehypertensive might have postponed the 
development of hypertension and the need for 
antihypertensive medication.
The high incidence of hypertension in our study might 
have been due to various biological and behavioural 
risk factors. A review27 reported that the incidence of 
hyper tension in south Asia ranges between 3% and 18%. 
A multicountry study28 from southern Asia also reported 
a high incidence (8·3%) of hypertension. The study28 also 
reported that the rate of progression to hypertension in 
individuals with prehypertension was three times the 
rate in individuals with normal blood pressure, which 
was similar to our results.
We assessed the combined effect of home-based 
blood pressure monitoring and an FCHV-led lifestyle 
inter vention, and did not assess the mechanisms by 
which the reduction in blood pressure was achieved. 
Although we could not find any significant difference 
in individual risk factors between the intervention and 
control groups, change in behavioural risk factors in 
the intervention group, compared with the control 
group, probably had synergistic beneficial effects. The 
personalised counselling delivered by FCHVs through 
home visits might have encouraged participants to 
adopt healthy lifestyles. Despite civil war, political 
instability, and natural disasters, the FCHV programme 
has continued to deliver essential health services in 
maternal and child health, in which health-promotion 
counselling is a major element.29
Studies in HICs have mainly assessed the role of 
community health workers in patients with 
hypertension and have had positive results.11 The 
characteristics (such as education, training, and 
recruitment) of community health workers in LMICs 
are different from, and cannot be compared to, those 
in HICs. In Nepal, FCHVs have a low level of education 
Normotension Prehypertension Hypertension
Intervention 
(n=425)
Control 
(n=305)
Intervention 
(n=175)
Control 
(n=128)
Intervention 
(n=255)
Control 
(n=180)
Systolic blood pressure (mm Hg) 4·39 6·61 0·42 2·88 –6·47 –2·85
Diastolic blood pressure (mm Hg) 4·58 5·12 1·48 2·52 –2·90 –1·11
Current smoker –0·47% 0·66% –0·57% 1·56% 0·78% 2·22%
Harmful alcohol consumption* 4·47% 4·59% –0·57% –4·69% 1·18% 0·00%
High salt intake† –2·59% –1·97% –8·57% –8·59% –0·78% –5·00%
Low physical activity‡ 1·18% 5·90% 0·00% 9·38% 0·78% 11·11%
Receiving antihypertensive medication§ 18·20% 20·00% 19·00% 21·95% 1·18% 4·44%
*Eight standard drinks per week for women and 15 per week for men. †More than 5 mg per day. ‡Less than 3000 metabolic equivalent of tasks. §For patients who were 
normotensive or prehypertensive at baseline, only patients who were hypertensive at follow- up were included in calculation.
Table 3: Change in outcome variables from baseline to follow- up
Systolic blood pressure Diastolic blood pressure
Regression coefficient 
(95% CI)
p value Regression coefficient 
(95% CI)
p value
Normotension –2·28 (–3·77 to –0·79) 0·003 –0·56 (–1·72 to 0·59) 0·341
Prehypertension –3·08 (–5·58 to –0·59) 0·015 –1·34 (–2·96 to 0·28) 0·104
Hypertension –4·90 (–7·78 to –2·00) 0·001 –2·63 (–4·59 to –0·67) 0·008
Table 4: Multilevel mixed-effects linear regression adjusted for age, sex, and baseline blood pressure
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and are semi-literate; in some other low-income 
settings, community health workers are often illiterate. 
Thus, the educational materials and training methods 
used for these interventions, and the strategies for 
implementation, will vary depending on the context of 
the health service. Robust research in different 
contexts is needed to fully understand the efficacy and 
effectiveness of these interventions.
Some community-based programmes have effectively 
reduced cardiovascular risk factors in LMIC settings.30 
A study31 in India showed that a community health worker-
based personalised intervention for acute coro nary 
syndrome improved adherence to healthy lifestyles. 
A study32 to reduce dietary salt intake in sub-Saharan Africa 
by mobilisation of community health workers lowered 
blood pressure levels in the short term. Another study12 in 
children and young adults (5–39 years) in Pakistan showed 
that the change in systolic blood pressure (1·5 mm Hg) in 
the intervention group compared with the control group 
(0·1 mm Hg) was significant (p=0·02). Compared with 
these previous studies, we achieved a greater decline in 
systolic blood pressure, which might be because we used 
FCHVs trained under the Ministry of Health’s FCHV 
programme and included older participants (25–65 years) 
who are more likely to be responsive to lifestyle 
interventions than younger individuals.33,34 Another study12 
in Pakistan concluded that a community health worker-led 
intervention for hyper tension management in patients 
with hypertension was effective when combined with 
education of patients by general practitioners’ (GPs) but 
not when used alone. Considering the shortage of GPs at 
the community level in many LMICs, provision of training 
in blood pressure screening and health promotion 
counselling to com munity health workers is a viable 
alternative to GP training in hyper tension management. 
In this study, FCHVs under the Ministry of Health 
provided health promotion counselling during home visits 
and regularly monitored the blood pressure of participants. 
Further studies are needed to explore the effectiveness of 
using community health workers to treat patients with 
hypertension at the community level.
Long-term trials with hard clinical outcomes, such as 
myocardial infarction and stroke, as primary endpoints 
are needed to confirm the effect of these interventions on 
cardiovascular morbidity and mortality. A large 
randomised trial with longer-term follow-up in the future 
might provide more robust results. However, we expect 
that the observed blood pressure reductions, 
if maintained over time, will lead to reductions in 
cardio vascular morbidity and mortality. Development of 
auto matic blood pressure monitoring devices, delivering 
audible blood pressure readings and displaying different 
colour signals for blood pressure classification, might 
help community health workers who are illiterate or 
semi-literate in low-resource settings such as Nepal. To 
ensure sustainability of the strategy, monitoring devices 
connected to solar panels could be more appropriate 
than traditional devices, which need recharging. Further 
studies of cost-effectiveness would be needed before the 
strategy could be scaled up and replicated.
Our study has some limitations. First, the duration of 
the trial was limited to 12 months, so we could not 
determine to what extent changes in blood pressure 
could be sustained, nor could we predict the effect of 
the intervention after 12 months. Second, use of 
clusters within the same municipality might have 
introduced some contamination, with the possibility of 
exchange of information between clusters. However, 
we assigned all FCHVs in one cluster to either provide 
or not provide the intervention. Furthermore, only 
FCHVs of clusters assigned to the intervention received 
training in blood pressure monitoring and provision of 
health promotion counselling. These precautions 
helped to minimise the risk of contamination. Third, 
the intervention was not designed to assess which 
elements of the intervention caused the beneficial 
effect, although our risk-factor analyses offered several 
clues. Fourth, the high incidence of hypertension in 
our study could be partly due to regression to the mean 
effect. Fifth, although we adjusted for sex in our 
analysis, because of the highly skewed sex distribution 
of the participants, the results might not be general-
isable to men, especially working men who are not 
always available for home-based visits.
Our study has several strengths. To our knowledge, this 
study is the first cluster-randomised controlled trial to 
report systolic blood pressure among normotensive, 
prehypertensive, and hypertensive populations through 
an existing network of community health workers. We 
mobilised existing health-care resources in real-life 
settings. Our sampling strategies ensured the recruitment 
of represen tative clusters. Furthermore, we used standard-
ised, reproducible, and low-cost tools and techniques and 
we trained FCHVs using standard training materials. The 
baseline and follow-up surveys were done by different 
data enumerators and the key outcome (blood pressure) 
was measured with an automated device, which 
minimised the risk of assessor’s bias.
Our intervention is simple in terms of design and 
logistics and, therefore, is ready for integration into 
existing health-care systems in LICs such as Nepal, 
where FCHVs have been part of the primary health-care 
system for the past 60 years. The findings resonate 
the call to action in the Lancet Commission on 
hypertension,35 which recommended expansion of the 
workforce engaged in management of blood pressure 
through task sharing and use of endorsed education in 
collaboration with community health workers. We 
found that a simple, community health worker-led 
lifestyle intervention coupled with monitoring of blood 
pressure was effective for blood pressure reduction in a 
general population in Nepal. This strategy is potentially 
feasible to scale up in countries with a strong network 
of community health workers.
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